This announcement is a separate document:
桂林三金：关于控股孙公司获得药物临床试验批准的公告
Guilin Sanjin Pharmaceutical: Announcement regarding the subsidiary obtaining approval for drug clinical trials.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.